d lin mc3 dma Search Results


97
MedChemExpress ionizable cationic lipid 6z 9z 28z 31z heptatriaconta 6 9 28 31 tetraen 19 yl
Ionizable Cationic Lipid 6z 9z 28z 31z Heptatriaconta 6 9 28 31 Tetraen 19 Yl, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+lin+mc3+dma/D-Lin-MC3-DMA/10__1016_slash_j__mtbio__2026__103340-65-1-9
Average 97 stars, based on 1 article reviews
ionizable cationic lipid 6z 9z 28z 31z heptatriaconta 6 9 28 31 tetraen 19 yl - by Bioz Stars, 2026-09
97/100 stars
  Buy from Supplier

N/A
D-Lin-MC3-DMA (CAT: I020230) is a potent siRNA delivery vehicle and falls under the category of ionizable amino lipids. It is specifically designed for efficient delivery of small interfering RNA (siRNA) molecules into cells. D-Lin-MC3-DMA possesses
  Buy from Supplier

93
Selleck Chemicals dlin mc3 dma
Dlin Mc3 Dma, supplied by Selleck Chemicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+lin+mc3+dma/D-Lin-MC3-DMA/pmc12257974-215-0-6
Average 93 stars, based on 1 article reviews
dlin mc3 dma - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

90
BroadPharm 6z,9z,28z,31z)-heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate (d-lin-mc3-dma
6z,9z,28z,31z) Heptatriaconta 6,9,28,31 Tetraen 19 Yl 4 (Dimethylamino)butanoate (D Lin Mc3 Dma, supplied by BroadPharm, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+lin+mc3+dma/6z+9z+28z+31z++heptatriaconta+6+9+28+31+tetraen+19+yl+4++dimethylamino+butanoate++d+lin+mc3+dma/pmc12031360-48-9-18
Average 90 stars, based on 1 article reviews
6z,9z,28z,31z)-heptatriaconta-6,9,28,31-tetraen-19-yl 4-(dimethylamino)butanoate (d-lin-mc3-dma - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
ChemScene llc d-lin-mc3-dma (mc3
Optimization of <t>MC3</t> lipid nanoparticles (A) Gel electrophoresis analysis of MC3 lipid nanoparticles (LNPs) at different N/P ratios. Arrowheads and arrows indicate nicked form and supercoiled form of double-strand DNA, respectively. (B) Encapsulation efficiency of luciferase mRNA LNP (Luc LNP) at N/P ratios of 3 and 8, determined by RiboGreen assay. (C) Evaluation of luciferase expression 6 h after intravenous injection of 0.3 mg/kg Luc LNPs at N/P ratios of 3 and 8 using IVIS imaging. (D) Quantification of luciferase expression from IVIS imaging, presented as mean luciferase signals ± standard deviations, expressed in bioluminescence light units (BLUs), N/P 3, n = 3; N/P 8, n = 6. Characterization of LNP: (E) size distribution and (F) average size at N/P ratio = 8 was analyzed using qNano. Examination of plasma (G) AST and (H) ALT levels 1 day after intravenous injection of 1 mg/kg Luc LNP.
D Lin Mc3 Dma (Mc3, supplied by ChemScene llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/d+lin+mc3+dma/d+lin+mc3+dma++mc3/pmc11617921-194-0-5
Average 90 stars, based on 1 article reviews
d-lin-mc3-dma (mc3 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier


N/A
Activity:Replacement of DSPC by unsaturated PCs and DLin-MC3-DMA by the related lipid DLin-KC2-DMA resulted in highly potent transfection reagents for HeLa cells in vitro.
  Buy from Supplier

N/A
D-Lin-MC3-DMA is the most potent cationic lipid that has been synthesized for lipid nanoparticles (LNPs) to deliver the siRNA. D-Lin-MC3-DMA is useful for design of lipid nanoparticles for in vitro and in vivo delivery of
  Buy from Supplier



Image Search Results


Optimization of MC3 lipid nanoparticles (A) Gel electrophoresis analysis of MC3 lipid nanoparticles (LNPs) at different N/P ratios. Arrowheads and arrows indicate nicked form and supercoiled form of double-strand DNA, respectively. (B) Encapsulation efficiency of luciferase mRNA LNP (Luc LNP) at N/P ratios of 3 and 8, determined by RiboGreen assay. (C) Evaluation of luciferase expression 6 h after intravenous injection of 0.3 mg/kg Luc LNPs at N/P ratios of 3 and 8 using IVIS imaging. (D) Quantification of luciferase expression from IVIS imaging, presented as mean luciferase signals ± standard deviations, expressed in bioluminescence light units (BLUs), N/P 3, n = 3; N/P 8, n = 6. Characterization of LNP: (E) size distribution and (F) average size at N/P ratio = 8 was analyzed using qNano. Examination of plasma (G) AST and (H) ALT levels 1 day after intravenous injection of 1 mg/kg Luc LNP.

Journal: Molecular Therapy. Nucleic Acids

Article Title: Rescue of the endogenous FVIII expression in hemophilia A mice using CRISPR-Cas9 mRNA LNPs

doi: 10.1016/j.omtn.2024.102383

Figure Lengend Snippet: Optimization of MC3 lipid nanoparticles (A) Gel electrophoresis analysis of MC3 lipid nanoparticles (LNPs) at different N/P ratios. Arrowheads and arrows indicate nicked form and supercoiled form of double-strand DNA, respectively. (B) Encapsulation efficiency of luciferase mRNA LNP (Luc LNP) at N/P ratios of 3 and 8, determined by RiboGreen assay. (C) Evaluation of luciferase expression 6 h after intravenous injection of 0.3 mg/kg Luc LNPs at N/P ratios of 3 and 8 using IVIS imaging. (D) Quantification of luciferase expression from IVIS imaging, presented as mean luciferase signals ± standard deviations, expressed in bioluminescence light units (BLUs), N/P 3, n = 3; N/P 8, n = 6. Characterization of LNP: (E) size distribution and (F) average size at N/P ratio = 8 was analyzed using qNano. Examination of plasma (G) AST and (H) ALT levels 1 day after intravenous injection of 1 mg/kg Luc LNP.

Article Snippet: D-Lin-MC3-DMA (MC3) was purchased from Chemscene (Monmouth Junction, NJ, USA) or MedKoo (Morrisville, NJ, USA).

Techniques: Nucleic Acid Electrophoresis, Encapsulation, Luciferase, Expressing, Injection, Imaging

Cell distribution of MC3 LNPs after intravenous injection in mice (A) One hour after intravenous injection of DiI-labeled LNPs (red) in mice, liver tissues were harvested and stained with FITC-Isolectin-B4 (green) to mark vascular cells. Colocalization of LNPs and vascular cells were indicated by white arrowheads. (B) To determine the LSEC-targeting ability, mice were intravenously injected with 1.2 mg/kg of GFP LNPs. Liver sections harvested 6 h after LNP injection were stained with anti-GFP (green) and anti-LYVE-1(red) antibodies. Co-stained cells were highlighted using white arrowheads. Enlarged images of the staining within white squares are presented below. (C) Mice were treated with 0.2 mg/kg Luc LNPs. Livers of treated mice were perfused with Liberase to obtain single cell suspensions. The total liver cells were subsequently purified to isolate hepatocytes (HPCs) and LSECs. Luciferase expression of HPCs and LSECs were determined by luciferase assay and normalized by total protein, respectively. Data are presented as average experimental values ± standard deviation.

Journal: Molecular Therapy. Nucleic Acids

Article Title: Rescue of the endogenous FVIII expression in hemophilia A mice using CRISPR-Cas9 mRNA LNPs

doi: 10.1016/j.omtn.2024.102383

Figure Lengend Snippet: Cell distribution of MC3 LNPs after intravenous injection in mice (A) One hour after intravenous injection of DiI-labeled LNPs (red) in mice, liver tissues were harvested and stained with FITC-Isolectin-B4 (green) to mark vascular cells. Colocalization of LNPs and vascular cells were indicated by white arrowheads. (B) To determine the LSEC-targeting ability, mice were intravenously injected with 1.2 mg/kg of GFP LNPs. Liver sections harvested 6 h after LNP injection were stained with anti-GFP (green) and anti-LYVE-1(red) antibodies. Co-stained cells were highlighted using white arrowheads. Enlarged images of the staining within white squares are presented below. (C) Mice were treated with 0.2 mg/kg Luc LNPs. Livers of treated mice were perfused with Liberase to obtain single cell suspensions. The total liver cells were subsequently purified to isolate hepatocytes (HPCs) and LSECs. Luciferase expression of HPCs and LSECs were determined by luciferase assay and normalized by total protein, respectively. Data are presented as average experimental values ± standard deviation.

Article Snippet: D-Lin-MC3-DMA (MC3) was purchased from Chemscene (Monmouth Junction, NJ, USA) or MedKoo (Morrisville, NJ, USA).

Techniques: Injection, Labeling, Staining, Purification, Luciferase, Expressing, Standard Deviation